Summary
The side effects associated with the use of Iopamidol for myelography were determined in 100 patients and compared with metrizamide in a double-blind study.
Similar content being viewed by others
References
Ahlgren, P.: Amipaque myelography without late leptomeningeal arachnoid changes. Neuroradiology 14, 231–233 (1978)
Belán, A., Benda, K., Fabián, J., Bláha, J.: Advantages of a new non ionic contrast medium. The results of animal experiments. Ann. Radiol. 21, 279–282 (1978)
Cecchini, A., Scotti, G., Rognone, F., Martelli, A.: Perliminary experiences about Iopamidol in myelography. 8th Congr. Europ. Soc. Neuroradiology, Strasbourg, Sept. 7–8, 1979
Cucchini, F., Di Donato, M., Baldi, G., Effendy, F.N., Bongrani, S., Colla, B., Visioli, O.: Ventriculografia sinistra e coronarografia selettiva con un nuovo mezzo di contrasto non ionizzato. G. Ital. Cardiol. 9, 744–752 (1979)
Dettori, P.: Iopamidol im myeloradiculography. Congr. Dtsch. Ges. Neuroradiol., Mannheim, May 10–12, 1979
Felder, E., Pitrè, D., Tirone, P.: Radiopaque contrast media. XLIV. Preclinical studies with a new nonionic contrast agent. Farmaco 32, 835–844 (1977)
Hammer, B.: Meningeale Spätveränderungen durch wasserlösliche Myelographiekontrastmittel. Fortschr. Röntgenstr. 126, 145–149 (1977)
Hammer, B.: Results of a double blind study of three contrast media and technic for lumbosacral radiculography. Neuroradiology 17, 45–50 (1978)
Juliani, G.: Un mezzo di contrasto organoiodato non ionico per angiografia e urografia. Prime sperimentazioni cliniche. G. Acad. Med. Torino 89, 1–7 (1977)
Skalpe, O.: Personal communication.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hammer, B., Lackner, W. Iopamidol, a new non-ionic hydrosoluble contrast medium for neuroradiology. Neuroradiology 19, 119–121 (1980). https://doi.org/10.1007/BF00342385
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00342385